All injections at the clinic bypass the digestive system to deliver active ingredients directly into the bloodstream and the new CBD injection is no exception – this compound is utilised by our bodies Endocannabinoid System and, when injected, CBD is not lost during the digestion process. As such, the maximum amount of the CBD compound is absorbed, ensuring better efficacy and health benefits.
Bianca Estelle, founder of Vitamin Injections London
Since the birth of this wellness trend, circa 2018, CBD (cannabidiol) has featured in countless health, beauty and food products, but, like many consumer-led products, due diligence should be carried out before investment to ensure you’re benefiting from the real deal.
What are the benefits?
By far, the most popular way to take CBD is with an oil or tincture, applied under the tongue, but, if we look at the best way to ensure that active ingredients (including vitamins) reach the bloodstream, there may be a better way. Enter Vitamin Injections London and its new CBD injection. Based in London’s affluent Marylebone, the clinic specialises in offering vitamin nutrient therapy, to promote health and wellbeing from the inside out.
Currently the most popular way of taking CBD is with an oil or tincture applied under the tongue
CBD stands for cannabidiol and is an active ingredient derived from the hemp plant, a cousin of the marijuana (cannabis) plant. Unlike THC, which is also found in marijuana, CBD doesn’t cause intoxication or a high and is therefore safe for use. In fact, there has been evidence to show that it can treat the symptoms of epilepsy but in recent times, its more widely adopted for its general health and wellness benefits.
Chances are, you’ve heard the initials CBD bandied around over the last few years and you may even have dabbled in CBD usage yourself, so popular is the ingredient in oil form. A few drops under the tongue for a better mood, you say? surely that’s worth a try. It’s hailed as a phenomenon for consumers seeking a healthier lifestyle with a strong desire to address anxiety and stress (two emotions that appear to underpin modern society).
Cannabis is widely used recreationally and for symptomatic relief in a number of ailments. However, cannabis has been implicated as a risk factor for the development of psychotic illness. For forty years researchers have utilised intravenous preparations of Δ(9)-THC, as well as several other phytocannabinoids, in a laboratory setting. The intravenous route has the most reliable pharmacokinetics, reducing inter-individual variation in bioavailability and is well suited for the delivery of synthetic compounds containing a sole pharmacological moiety. Given the association between cannabinoids and psychotic illness, there has been a resurgence of interest in experimental studies of cannabinoids in humans, and the intravenous route has been employed. Here in a critical review, we appraise the major findings from recent intravenous cannabinoid studies in humans and trace the historical roots of this work back to the 1970’s.